These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 36580)

  • 1. [beta-Adrenergic blockade and circadian variations of IRI].
    Cucinotta D; Quartarone M; Saitta A; Bonaiuto M; Longo G; Squadrito G
    Minerva Med; 1979 May; 70(22):1617-22. PubMed ID: 36580
    [No Abstract]   [Full Text] [Related]  

  • 2. [Circadian variations of immunoreactive insulin and beta-receptors blockade].
    Quartarone M; Cucinotta D; Saitta A; Perdichizzi G; Squadrito G
    Boll Soc Ital Biol Sper; 1978 Oct; 54(20):1985-91. PubMed ID: 753288
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man.
    Walter RM; Dudl RJ; Palmer JP; Ensinck JW
    J Clin Invest; 1974 Nov; 54(5):1214-20. PubMed ID: 4153713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of adrenergic beta-blocking agents on the serum insulin and glucagon response to oral glucose load in normal and diabetic subjects].
    Ferlito S; Volpicelli D; Del Campo F; Romano F; Modica L
    Clin Ter; 1981 May; 97(4):333-47. PubMed ID: 6113914
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic intervention in surgical patients: the effect of alpha- or beta-blockade on glucose and protein metabolism in surgical patients receiving total parenteral nutrition.
    Shaw JH; Holdaway CM; Humberstone DA
    Surgery; 1988 May; 103(5):520-5. PubMed ID: 2896394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Circadian variations of IRI, during fasting, in normal, obese and diabetic subjects].
    Cucinotta D; Quartarone M; Saitta A; Miceli A; Squadrito G
    Minerva Med; 1979 May; 70(23):1659-66. PubMed ID: 450306
    [No Abstract]   [Full Text] [Related]  

  • 7. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioselective (metoprolol) and non-selective (propranolol) beta-blockade and glucose homeostasis.
    Syvälahti E; Lammintausta R; Iisalo E; Kanto J
    Ann Clin Res; 1977 Oct; 9(5):292-5. PubMed ID: 616215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Circulatory responses to insulin administration in the rabbit. 2. Effects of adrenergic blockade.
    Asano M; Ookubo C
    Jpn J Pharmacol; 1974; 24(0):s:70. PubMed ID: 4151713
    [No Abstract]   [Full Text] [Related]  

  • 10. No effect of beta-adrenergic blockade on hypoglycaemic effect of glucagon-like peptide-1 (GLP-1) in normal subjects.
    Toft-Nielsen M; Hvidberg A; Hilsted J; Dige-Petersen H; Holst JJ
    Diabet Med; 1996 Jun; 13(6):544-8. PubMed ID: 8799658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of a beta-blocking agent on the adipokinetic action of corticotropin in humans].
    Giordano G; Marcenaro A; Pompei A
    Arch Maragliano Patol Clin; 1970; 26(4):239-57. PubMed ID: 4394963
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of trimepranol on somatotropin, insulin, glucose and on serum free fatty acids in thyrotoxicosis].
    Felt V; Nedvídková J
    Vnitr Lek; 1973 Apr; 19(4):374-8. PubMed ID: 4144647
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
    Bowden CR; Marchione CS
    J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian and circannual variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in elderly subjects.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Popescu M; Petrescu E; Sackett-Lundeen L; Stelea P; Stelea S
    Endocrinologie; 1983; 21(4):243-55. PubMed ID: 6364319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fasting on the circadian rhythm of serum insulin levels.
    Pessacq MT; Mercer RG; Rebolledo OR; Gagliardino JJ
    Chronobiologia; 1976; 3(1):20-6. PubMed ID: 1277967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin secretion and beta-adrenergic blockade in normal subjects, obese subjects and obese diabetics after carbohydrate stimulation].
    Saitta A; Quartarone M; Cucinotta D; Mangano C; Pizzoleo MA; Squadrito G
    Minerva Med; 1979 May; 70(22):1611-5. PubMed ID: 36579
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenergic, insulin, and work interactions with adenosine's effects on in situ myocardial glucose uptake.
    Law WR; McLane MP
    Cardiovasc Res; 1996 May; 31(5):691-8. PubMed ID: 8763398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treadmill investigations into the action of beta receptor antagonists on blood pressure and pulse rate.
    Kirchhoff HW
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):141-4. PubMed ID: 4395479
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of adrenergic receptors in the increased glucose uptake by the canine gut.
    Alada AR; Oyebola DD
    Afr J Med Med Sci; 1997; 26(1-2):75-8. PubMed ID: 10895237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic regulation of circadian rhythmicity of the renin-angiotensin-aldosterone system in five subtypes of essential hypertension.
    Cugini P; Manconi R; Mancini A; Serdoz R; Meucci T; Scavo D
    G Ital Cardiol; 1980; 10(2):184-90. PubMed ID: 6102942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.